Want to join the conversation?
With regards to developments in 3Q15, $REGN currently has multiple Phase 3 studies of dupilumab that are underway. $REGN expect these studies to be fully enrolled by the end of the year with final data expected in 2017. The Phase 2 study in atopic dermatitis in adolescents and children completed enrollment.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?